During the past decade, Pusan National University Hospital conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 10 clinical trials were completed, i.e. on average, 15.6% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 5 clinical trials were completed. i.e. 21.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pusan National University Hospital" #1 sponsor was "Seung-Jung Park" with 12 trials, followed by "Seoul National University Hospital" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Samsung Medical Center" with 5 trials sponsored and "Chonnam National University Hospital" with 5 trials sponsored. Other sponsors include 67 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pusan National University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 13 trials as a collaborator, "Pusan National University Hospital" with 5 trials as a collaborator, "Inje University" with 3 trials as a collaborator, "Korea University Guro Hospital" with 3 trials as a collaborator and "Abbott" with 2 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "Pusan National University Hospital" are "Coronary Artery Disease" (20 trials), "Myocardial Infarction" (4 trials), "Rheumatoid Arthritis" (4 trials), "Atrial Fibrillation" (3 trials) and "Coronary Disease" (3 trials). Many other conditions were trialed in "Pusan National University Hospital" in a lesser frequency.

Most popular intervention types in "Pusan National University Hospital" are "Drug" (52 trials), "Device" (19 trials), "Biological" (9 trials), "Procedure" (7 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Cisplatin" (3 trials), "Amlodipine 10mg" (2 trials), "Amlodipine 5mg" (2 trials) and "Aspirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pusan National University Hospital" are 100 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pusan National University Hospital". undefined are not yet recruiting, 24 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Pusan National University Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Pusan National University Hospital, 5 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 19 trials that are defined as “Not Applicable".